Prism Medico And Pharmacy Limited convened its 24th Annual General Meeting on September 19, 2026. Shareholders approved the audited standalone financial statements for the fiscal year ending March 31, 2026, along with the reports of the Board of Directors and Auditors. The meeting also saw the re-appointment of statutory auditors and the appointment of directors and secretarial auditors.
Prism Medico Holds 24th Annual General Meeting
Prism Medico And Pharmacy Limited successfully conducted its 24th Annual General Meeting (AGM) on Saturday, September 19, 2026. The meeting commenced at 12:30 PM and concluded at 12:42 PM, conducted virtually via Video Conferencing and Other Audio-Visual Means. The proceedings were chaired by Mrs. Sakshi Laller, a Wholetime Director.
Key Business Transacted
During the AGM, shareholders were presented with and approved the Ordinary Business items, including the Audited Standalone Financial Statements for the financial year ended March 31, 2026, along with the associated reports. The meeting also addressed Special Business items.
Director Appointments and Re-appointments
Shareholders approved the appointment of a Director in place of Mr. Davender Singh, who was eligible for re-appointment. Furthermore, M/s. Garg Mendiratta and Associates were re-appointed as the statutory auditors of the company, with their remuneration to be fixed accordingly. M/s. SDK & Associates were appointed as the Secretarial Auditors for a period of five financial years, from 2026-27 to 2030-31.
Approval of Varied Business Items
The AGM also saw the approval for variations in the objects of a Preferential Issue and the utilization of its proceeds, as previously approved by members on March 20, 2026. Shareholders also approved the company’s investment of funds in the securities of M/s. Infuze Well Private Limited, as well as material related party transactions, including a strategic investment by way of subscription to equity shares of M/s. Infuze Well Private Limited.
The company confirmed that there were no queries raised by any shareholder during the meeting. The voting results on the resolutions passed will be communicated to the stock exchanges following the receipt of the Scrutinizer’s Report.
Source: BSE